A new paper presents a computational pipeline for designing peptide binders, aiming to fix cases where deep learning confidence scores mislead.
Recap by typeshit. Post by Biology+AI Daily on X.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
Research shared by Romesh Vaitilingam ties GLP-1 treatment to fewer long sickness absences, emergency visits and heart medication use.
Loading…